186 related articles for article (PubMed ID: 18446505)
1. Pharmacokinetic interaction between the flavonoid luteolin and gamma-hydroxybutyrate in rats: potential involvement of monocarboxylate transporters.
Wang X; Wang Q; Morris ME
AAPS J; 2008; 10(1):47-55. PubMed ID: 18446505
[TBL] [Abstract][Full Text] [Related]
2. Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo.
Wang Q; Morris ME
Drug Metab Dispos; 2007 Feb; 35(2):201-8. PubMed ID: 17108059
[TBL] [Abstract][Full Text] [Related]
3. Transport of gamma-hydroxybutyrate in rat kidney membrane vesicles: Role of monocarboxylate transporters.
Wang Q; Darling IM; Morris ME
J Pharmacol Exp Ther; 2006 Aug; 318(2):751-61. PubMed ID: 16707723
[TBL] [Abstract][Full Text] [Related]
4. GHB toxicokinetics and renal monocarboxylate transporter expression are influenced by the estrus cycle in rats.
Wei H; Cao J; Fallert T; Yeo S; Felmlee MA
BMC Pharmacol Toxicol; 2023 Nov; 24(1):58. PubMed ID: 37919807
[TBL] [Abstract][Full Text] [Related]
5. Effects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of γ-hydroxybutyrate and γ-butyrolactone.
Morse BL; Morris ME
J Pharmacol Exp Ther; 2013 Apr; 345(1):102-10. PubMed ID: 23392755
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic modeling of monocarboxylate transporter-mediated toxicokinetic/toxicodynamic interactions between γ-hydroxybutyrate and L-lactate.
Morse BL; Vijay N; Morris ME
AAPS J; 2014 Jul; 16(4):756-70. PubMed ID: 24854892
[TBL] [Abstract][Full Text] [Related]
7. The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition.
Cui D; Morris ME
Drug Metab Dispos; 2009 Jul; 37(7):1404-10. PubMed ID: 19389857
[TBL] [Abstract][Full Text] [Related]
8. Drug-drug interaction between diclofenac and gamma-hydroxybutyric acid.
Rodriguez-Cruz V; Ren T; Morris ME
Biopharm Drug Dispos; 2021 Sep; 42(8):351-358. PubMed ID: 34191301
[TBL] [Abstract][Full Text] [Related]
9.
Rodriguez-Cruz V; Morris ME
J Pharmacol Exp Ther; 2021 Jul; 378(1):42-50. PubMed ID: 33963018
[TBL] [Abstract][Full Text] [Related]
10. γ-Hydroxybutyrate blood/plasma partitioning: effect of physiologic pH on transport by monocarboxylate transporters.
Morse BL; Felmlee MA; Morris ME
Drug Metab Dispos; 2012 Jan; 40(1):64-9. PubMed ID: 21976619
[TBL] [Abstract][Full Text] [Related]
11. Effects of L-lactate and D-mannitol on gamma-hydroxybutyrate toxicokinetics and toxicodynamics in rats.
Wang Q; Wang X; Morris ME
Drug Metab Dispos; 2008 Nov; 36(11):2244-51. PubMed ID: 18719239
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression.
Morse BL; Chadha GS; Felmlee MA; Follman KE; Morris ME
Am J Drug Alcohol Abuse; 2017 Nov; 43(6):686-693. PubMed ID: 28662343
[TBL] [Abstract][Full Text] [Related]
13. A Novel Monocarboxylate Transporter Inhibitor as a Potential Treatment Strategy for γ-Hydroxybutyric Acid Overdose.
Vijay N; Morse BL; Morris ME
Pharm Res; 2015 Jun; 32(6):1894-906. PubMed ID: 25480120
[TBL] [Abstract][Full Text] [Related]
14. Toxicokinetics/Toxicodynamics of γ-hydroxybutyrate-ethanol intoxication: evaluation of potential treatment strategies.
Morse BL; Morris ME
J Pharmacol Exp Ther; 2013 Sep; 346(3):504-13. PubMed ID: 23814094
[TBL] [Abstract][Full Text] [Related]
15. Monocarboxylate transporter (MCT) mediates the transport of gamma-hydroxybutyrate in human kidney HK-2 cells.
Wang Q; Lu Y; Morris ME
Pharm Res; 2007 Jun; 24(6):1067-78. PubMed ID: 17377745
[TBL] [Abstract][Full Text] [Related]
16. The role of monocarboxylate transporter 2 and 4 in the transport of gamma-hydroxybutyric acid in mammalian cells.
Wang Q; Morris ME
Drug Metab Dispos; 2007 Aug; 35(8):1393-9. PubMed ID: 17502341
[TBL] [Abstract][Full Text] [Related]
17. The Drug of Abuse Gamma-Hydroxybutyric Acid Exhibits Tissue-Specific Nonlinear Distribution.
Felmlee MA; Morse BL; Follman KE; Morris ME
AAPS J; 2017 Dec; 20(1):21. PubMed ID: 29280004
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic toxicokinetic model for gamma-hydroxybutyric acid: inhibition of active renal reabsorption as a potential therapeutic strategy.
Felmlee MA; Wang Q; Cui D; Roiko SA; Morris ME
AAPS J; 2010 Sep; 12(3):407-16. PubMed ID: 20461486
[TBL] [Abstract][Full Text] [Related]
19. Brain extracellular γ-hydroxybutyrate concentrations are decreased by L-lactate in rats: role in the treatment of overdoses.
Roiko SA; Vijay N; Felmlee MA; Morris ME
Pharm Res; 2013 May; 30(5):1338-48. PubMed ID: 23319173
[TBL] [Abstract][Full Text] [Related]
20. Semi-mechanistic kidney model incorporating physiologically-relevant fluid reabsorption and transporter-mediated renal reabsorption: pharmacokinetics of γ-hydroxybutyric acid and L-lactate in rats.
Dave RA; Morris ME
J Pharmacokinet Pharmacodyn; 2015 Oct; 42(5):497-513. PubMed ID: 26341876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
